{
    "clinical_study": {
        "@rank": "63613", 
        "arm_group": [
            {
                "arm_group_label": "PEG-S", 
                "arm_group_type": "Experimental", 
                "description": "polyethylene glycol 4000 solution with simethicon"
            }, 
            {
                "arm_group_label": "PEG-CS + Bisacodyl", 
                "arm_group_type": "Experimental", 
                "description": "PEG-CS is a new sulphate-free iso-osmotic formulation of PEG-4000 with citrates and simethicone"
            }, 
            {
                "arm_group_label": "PEG-ASC", 
                "arm_group_type": "Experimental", 
                "description": "polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid"
            }, 
            {
                "arm_group_label": "picoprep", 
                "arm_group_type": "Experimental", 
                "description": "sodium picosulphate plus magnesium oxide and citric acid"
            }
        ], 
        "brief_summary": {
            "textblock": "THE AIM OF THIS STUDY IS TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT\n      BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN.\n\n      THE AIM OF THIS STUDY IS TO COMPARE  THE OVERALL COLON CLEANSING"
        }, 
        "brief_title": "Different Bowel Preparations for Colonoscopy In Children", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Colonoscopy", 
        "detailed_description": {
            "textblock": "COLONOSCOPY IS AN ESTABLISHED DIAGNOSTIC AND THERAPEUTIC TOOL IN A VARIETY OF\n      GASTROINTESTINAL TRACT CONDITION AFFECTING CHILDREN AND ADOLESCENTs. FOR EXAMPLE:\n      INFLAMMATORY BOWEL DISEASE, COLONIC POLYPS OR LOWER GASTROINTESTINAL TRACT BLEEDING.\n\n      THE IDEAL PREPARATION SHOULD BE OF LOW VOLUME, PALATABLE AND SUCCESSFUL IN COMPLETE COLON\n      CLEANOUT.\n\n      PRIMARY AIMS OF THIS WERE TO COMPARE THE EFFICACY AND ACCEPTANCE OF FOUR METHODS OF BOWEL\n      CLEANSING BEFORE COLONOSCOPY IN CHILDREN. SECONDARY AIMS WAS TO COMPARE THE SAFETY PROFILE\n      OF THIS METHODS."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing elective colonoscopy in our Institution between 2 and 18 years of\n             age were recruited for this study.\n\n        Exclusion Criteria:\n\n          1. requirement for urgent colonoscopy,\n\n          2. bowel obstruction,\n\n          3. known or suspected hypersensitivity to the active or other ingredients,\n\n          4. clinically significant electrolyte imbalance,\n\n          5. prior intestinal resection,\n\n          6. known metabolic, renal and cardiac disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711437", 
            "org_study_id": "PEG-P2"
        }, 
        "intervention": [
            {
                "arm_group_label": "PEG-CS + Bisacodyl", 
                "description": "1-4 bisacodyl 5-mg tablets (Lovoldyl) at 16:00, followed 2-3 hours later by 50 ml/kg (maximum 2 L) of PEG-CS solution. The patients were instructed to drink all solution in about 2-3 hours.", 
                "intervention_name": "PEG-4000 with citrates and simethicone", 
                "intervention_type": "Device", 
                "other_name": "lovol-esse"
            }, 
            {
                "arm_group_label": "PEG-S", 
                "description": "patients received a polyethylene glycol 4000 solution with simethicon (Selg Esse) starting at 3:00 p.m. the day before the colonoscopy at a dose of 100 ml/Kg (maximum 4 L). The patients were instructed to drink all solution in about 4-6 hours.", 
                "intervention_name": "polyethylene glycol 4000 solution with simethicon", 
                "intervention_type": "Device", 
                "other_name": "selg-esse"
            }, 
            {
                "arm_group_label": "PEG-ASC", 
                "description": "patients received a polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid (Moviprep)  a dose of 50 ml/Kg (maximum 2 L) with 25 ml/kg additional clear fluid after completing solution intake.", 
                "intervention_name": "polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid", 
                "intervention_type": "Device", 
                "other_name": "moviprep"
            }, 
            {
                "arm_group_label": "picoprep", 
                "description": "patients received two sachets of sodium picosulphate plus magnesium oxide and citric acid (Picoprep), each diluted in 150 ml of water, at 14:00 and 6 hours later in the evening prior to the colonoscopy. Intake of at least 40-50 ml/kg of clear fluids", 
                "intervention_name": "sodium picosulphate plus magnesium oxide and citric acid", 
                "intervention_type": "Device", 
                "other_name": "Picoprep"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ascorbic Acid", 
                "Citric Acid", 
                "Magnesium Oxide", 
                "Simethicone", 
                "Picosulfate sodium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colonoscopy", 
            "colon cleansing", 
            "children", 
            "age 2 -18 years"
        ], 
        "lastchanged_date": "November 5, 2012", 
        "location": {
            "contact": {
                "email": "giovanni.dinardo@uniroma1.it", 
                "last_name": "Dipartimento di pediatria e neuropsichiatria Policlinico umberto l \"universit\u00e0 di roma la sapienza\"", 
                "phone": "0649979326"
            }, 
            "facility": {
                "address": {
                    "city": "Roma", 
                    "country": "Italy", 
                    "zip": "00161"
                }, 
                "name": "Dipartimento di pediatria e neuropsichiatria Policlinico umberto l \"universit\u00e0 di roma la sapienza\""
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "4", 
        "official_title": "EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Preparation efficacy was evaluated by the blinded endoscopist according to the Boston Bowel Preparation scale (BBPS) consisting of four-point scoring system.\nThe total score ranging from 0 to 9 was divided into four different classes: excellent cleansing (total score 8-9), good cleansing (total score 6-7), poor cleansing (total score 4-5) and inadequate cleansing (total score 0-3).", 
            "measure": "Efficacy", 
            "safety_issue": "No", 
            "time_frame": "During the performance of colonoscopy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711437"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Azienda Policlinico Umberto I", 
            "investigator_full_name": "Giovanni Di Nardo", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Adverse events were assessed on the day of colonoscopy by direct questioning and by telephone interview 48-96 hours after colonoscopy.", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "4 days"
            }, 
            {
                "description": "Tolerability assessment was based on the recording of occurrence and severity of GI symptoms such as nausea, bloating, abdominal, pain/cramps and anal discomfort", 
                "measure": "clinical tolerabiity", 
                "safety_issue": "Yes", 
                "time_frame": "On the morning of colonoscopy, immediately before the procedure"
            }, 
            {
                "description": "Compliance was scored on a 3-point scale according to the percentage of drunk solution", 
                "measure": "Compliance", 
                "safety_issue": "No", 
                "time_frame": "On the morning of colonoscopy, immediately before the procedure"
            }, 
            {
                "description": "The easiness of taking or swallowing the solution was graded according to the following scale: very severe distress = 4, severe distress = 3, moderate distress = 2, mild distress = 1, no distress = 0.", 
                "measure": "Acceptability", 
                "safety_issue": "No", 
                "time_frame": "On the morning of colonoscopy, immediately before the procedure"
            }
        ], 
        "source": "Azienda Policlinico Umberto I", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azienda Policlinico Umberto I", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}